Booth: 2612
DecisionDx-SCC is a validated 40-GEP test that is designed to identify the risk of nodal or distant metastasis in squamous cell carcinoma (SCC) patients with one or more risk factors, based on the biological profile of 40 genes within their tumor tissue. It is the strongest independent predictor of SCC metastasis. DecisionDx-SCC results deliver precision patient classification, complementing commonly used traditional risk factors and improving risk assessment in SCC to inform key clinical management decisions:
• Adjuvant radiation therapy (ART)
• Nodal evaluation; imaging and sentinel lymph node biopsy (SLNB)
• Frequency of follow-up and surveillance
